SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-072387
Filing Date
2019-12-13
Accepted
2019-12-13 09:00:29
Documents
4
Period of Report
2019-12-13
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1925011-1_8k.htm 8-K 30931
2 EXHIBIT 3.1 tm1925011d1_ex3-1.htm EX-3.1 15159
3 EXXHIBIT 3.2 tm1925011d1_ex3-2.htm EX-3.2 110606
4 GRAPHIC tm1925011d1_8kimg001.jpg GRAPHIC 5611
  Complete submission text file 0001104659-19-072387.txt   166493
Mailing Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341
Business Address 405 EAGLEVIEW BOULEVARD EXTON PA 19341 484-713-6000
Fibrocell Science, Inc. (Filer) CIK: 0000357097 (see all company filings)

IRS No.: 870458888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31564 | Film No.: 191283508
SIC: 2834 Pharmaceutical Preparations